Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas M Douglas

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Australian and New Zealand Journal of Public Health|October 9, 2009
Absence of significant dissent should be sufficient for deceased donor organ procurement in New ZealandThomas M Douglas, Nicholas M Douglas
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2018
Expanding the Use of Primaquine for the Radical Cure of Plasmodium vivaxRic N Price, Nicholas M Douglas
The Lancet. Infectious Diseases|September 14, 2010
Maximising the public health benefit of antimalarialsRic N Price, Nicholas M Douglas
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2009
Artemisinin combination therapy for malaria: beyond good efficacyRic N Price, Nicholas M Douglas
Journal of Paediatrics and Child Health|February 24, 2007
Survival by ethnicity for children diagnosed with cancer in New Zealand during 1990-1993Nicholas M Douglas, John D Dockerty
The New Zealand Medical Journal|February 2, 2023
A case of purpura fulminans attributed to trimethoprim-sulfamethoxazoleYassar Alamri, Ignatius Chua, Nicholas M Douglas
Pathology|August 21, 2020
Use of a rapid faeces multiplex PCR assay for diagnosis of amoebic liver abscessNicholas M Douglas, Robert W Baird, Bart J Currie
Tropical Medicine and Infectious Disease|April 25, 2025
A Review of the Efficacy, Safety, and Feasibility of Rifamycin-Based Post-Exposure Chemoprophylaxis for LeprosyPatrick O Campbell, Nicholas M Douglas, Stephen T Chambers
Current Opinion in Infectious Diseases|July 3, 2009
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistanceRic N Price, Nicholas M Douglas, Nicholas M Anstey
International Journal of Epidemiology|December 17, 2021
Malaria eradication revisitedNicholas M Douglas, Thomas R Burkot, Ric N Price
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Australian and New Zealand Journal of Public Health|October 9, 2009
Absence of significant dissent should be sufficient for deceased donor organ procurement in New ZealandThomas M Douglas, Nicholas M Douglas
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2018
Expanding the Use of Primaquine for the Radical Cure of Plasmodium vivaxRic N Price, Nicholas M Douglas
The Lancet. Infectious Diseases|September 14, 2010
Maximising the public health benefit of antimalarialsRic N Price, Nicholas M Douglas
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2009
Artemisinin combination therapy for malaria: beyond good efficacyRic N Price, Nicholas M Douglas
Journal of Paediatrics and Child Health|February 24, 2007
Survival by ethnicity for children diagnosed with cancer in New Zealand during 1990-1993Nicholas M Douglas, John D Dockerty
The New Zealand Medical Journal|February 2, 2023
A case of purpura fulminans attributed to trimethoprim-sulfamethoxazoleYassar Alamri, Ignatius Chua, Nicholas M Douglas
Pathology|August 21, 2020
Use of a rapid faeces multiplex PCR assay for diagnosis of amoebic liver abscessNicholas M Douglas, Robert W Baird, Bart J Currie
Tropical Medicine and Infectious Disease|April 25, 2025
A Review of the Efficacy, Safety, and Feasibility of Rifamycin-Based Post-Exposure Chemoprophylaxis for LeprosyPatrick O Campbell, Nicholas M Douglas, Stephen T Chambers
Current Opinion in Infectious Diseases|July 3, 2009
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistanceRic N Price, Nicholas M Douglas, Nicholas M Anstey
International Journal of Epidemiology|December 17, 2021
Malaria eradication revisitedNicholas M Douglas, Thomas R Burkot, Ric N Price
Pageof 6